Henry Schein, Inc. (NASDAQ:HSIC) Director Sells $124,747.68 in Stock

Henry Schein, Inc. (NASDAQ:HSIC) Director Paul Brons sold 1,758 shares of the stock in a transaction that occurred on Wednesday, June 12th. The stock was sold at an average price of $70.96, for a total transaction of $124,747.68. Following the completion of the sale, the director now owns 17,582 shares in the company, valued at $1,247,618.72. The transaction was disclosed in a filing with the SEC, which is available through this link.

Henry Schein stock opened at $71.28 on Friday. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.93 and a current ratio of 1.65. The firm has a market cap of $10.63 billion, a PE ratio of 17.26, a P/E/G ratio of 2.49 and a beta of 0.82. Henry Schein, Inc. has a fifty-two week low of $56.58 and a fifty-two week high of $91.35.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, May 7th. The company reported $0.80 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.76 by $0.04. The firm had revenue of $2.36 billion for the quarter, compared to analysts’ expectations of $2.36 billion. Henry Schein had a net margin of 4.10% and a return on equity of 18.35%. The business’s quarterly revenue was up 3.8% on a year-over-year basis. During the same quarter last year, the company posted $0.95 EPS. As a group, equities analysts forecast that Henry Schein, Inc. will post 3.45 earnings per share for the current year.

Several research firms have issued reports on HSIC. Royal Bank of Canada lowered their target price on shares of Henry Schein to $62.00 and set a “sector perform” rating on the stock in a research note on Thursday, February 21st. BidaskClub upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a research note on Friday, April 26th. Zacks Investment Research upgraded shares of Henry Schein from a “hold” rating to a “buy” rating and set a $78.00 target price on the stock in a research note on Monday, May 13th. Barrington Research increased their target price on shares of Henry Schein from $72.00 to $75.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 8th. Finally, Svb Leerink reiterated a “market perform” rating and issued a $70.00 target price (down from $75.00) on shares of Henry Schein in a research note on Wednesday, May 15th. Seven analysts have rated the stock with a sell rating, nine have given a hold rating and four have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $74.27.

Several institutional investors have recently bought and sold shares of the company. Evergreen Capital Management LLC raised its position in shares of Henry Schein by 0.4% during the 1st quarter. Evergreen Capital Management LLC now owns 39,314 shares of the company’s stock valued at $2,363,000 after buying an additional 151 shares in the last quarter. AGF Investments Inc. raised its position in shares of Henry Schein by 6.3% during the 1st quarter. AGF Investments Inc. now owns 2,652 shares of the company’s stock valued at $159,000 after buying an additional 157 shares in the last quarter. Utah Retirement Systems raised its position in shares of Henry Schein by 0.6% during the 1st quarter. Utah Retirement Systems now owns 28,628 shares of the company’s stock valued at $1,721,000 after buying an additional 178 shares in the last quarter. Mission Wealth Management LP raised its position in shares of Henry Schein by 4.4% during the 4th quarter. Mission Wealth Management LP now owns 4,329 shares of the company’s stock valued at $340,000 after buying an additional 182 shares in the last quarter. Finally, Wilbanks Smith & Thomas Asset Management LLC raised its position in shares of Henry Schein by 5.9% during the 4th quarter. Wilbanks Smith & Thomas Asset Management LLC now owns 3,368 shares of the company’s stock valued at $264,000 after buying an additional 189 shares in the last quarter.

TRADEMARK VIOLATION WARNING: This story was originally published by Markets Daily and is the property of of Markets Daily. If you are viewing this story on another domain, it was illegally stolen and republished in violation of US and international copyright and trademark legislation. The original version of this story can be read at https://www.themarketsdaily.com/2019/06/16/henry-schein-inc-nasdaqhsic-director-sells-124747-68-in-stock.html.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Story: Exchange-Traded Funds (ETFs)

Insider Buying and Selling by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.